A Phase 1, Partially-Blind, Placebo Controlled, Randomized, Combined Single Ascending Dose With a Food Effect Cohort and Multiple Ascending Dose and a Drug-Drug Interaction Study to Evaluate the Safety, Tolerability, Pharmacokinetics and the Pharmacokinetic Interaction Between TBA-7371 With Midazolam and Bupropion in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2018
At a glance
- Drugs TBA 7371 (Primary) ; Bupropion; Midazolam
- Indications Tuberculosis
- Focus Adverse reactions
- 07 Sep 2017 Status changed from not yet recruiting to recruiting.
- 28 Aug 2017 Planned initiation date changed from 1 Jul 2017 to 1 Aug 2017.
- 29 Jun 2017 New trial record